AC
CMPS

Armistice Capital’s Compass Pathways CMPS Stock Holding History

Armistice Capital’s Portfolio CMPS Stock Details CMPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400,000
Closed -$2.96M – 317
2023
Q3 		$2.96M Buy
+400,000
New +$3.54M 0.05% 125

Other funds holding CMPS

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Armistice Capital's CMPS Position: Q4 2023 in Review

Armistice Capital sold out of Compass Pathways (CMPS) in Q4 2023, closing a stake of 400,000 shares — an estimated $2.96M sold.

Armistice Capital first reported a position in CMPS in Q3 2023 and held it in 1 quarter. The position peaked at $2.96M in Q3 2023. 126 funds tracked by Wall St. Rank hold CMPS as of Q4 2023.

  • Armistice Capital reported no remaining Compass Pathways position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 400,000 Compass Pathways shares in Q4 2023, an estimated $2.96M.
  • Armistice Capital first reported a position in Compass Pathways in Q3 2023 and held it in 1 quarter.
  • Armistice Capital's Compass Pathways position peaked at $2.96M in Q3 2023.
  • 126 funds tracked by Wall St. Rank held Compass Pathways as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.